EA200200656A1 - NEW THERAPEUTIC COMBINATIONS (S) -2- (BENZYLAMINOMETYL) -2,3,8,9-TETRAHYDRO-7H-1,4-DIOXIN [2,3-th] INDOL-8-SHE AND NEUROLEPTIC FOR TREATMENT OR PREVENTION OF PSYCHOLOGICAL - Google Patents

NEW THERAPEUTIC COMBINATIONS (S) -2- (BENZYLAMINOMETYL) -2,3,8,9-TETRAHYDRO-7H-1,4-DIOXIN [2,3-th] INDOL-8-SHE AND NEUROLEPTIC FOR TREATMENT OR PREVENTION OF PSYCHOLOGICAL

Info

Publication number
EA200200656A1
EA200200656A1 EA200200656A EA200200656A EA200200656A1 EA 200200656 A1 EA200200656 A1 EA 200200656A1 EA 200200656 A EA200200656 A EA 200200656A EA 200200656 A EA200200656 A EA 200200656A EA 200200656 A1 EA200200656 A1 EA 200200656A1
Authority
EA
Eurasian Patent Office
Prior art keywords
benzylaminometyl
neuroleptic
dioxin
indol
psychological
Prior art date
Application number
EA200200656A
Other languages
Russian (ru)
Other versions
EA005002B1 (en
Inventor
Карен Лавелл Марквис
Original Assignee
Уайт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Уайт filed Critical Уайт
Publication of EA200200656A1 publication Critical patent/EA200200656A1/en
Publication of EA005002B1 publication Critical patent/EA005002B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Предоставляются терапевтические комбинации, которые можно применять при лечении или предотвращении психотических расстройств, фармацевтические композиции, содержащие указанные комбинации, и их применение при лечении или предотвращении психотических расстройств.Отчет о международном поиске был опубликован 2002.02.14.Therapeutic combinations that can be used in treating or preventing psychotic disorders, pharmaceutical compositions containing these combinations, and their use in treating or preventing psychotic disorders are provided. The international search report was published 2002.02.14.

EA200200656A 1999-12-10 2000-12-07 NOVEL THERAPEUTIC COMBINATIONS OF (S)-2(BENZYLAMINO-METHYL)-2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO(2,3-e)-INDOL-8-ONE AND NEUROLEPTICS FOR TREATING OR PREVENTION OF PSYCHOTIC DISORDERS EA005002B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45860799A 1999-12-10 1999-12-10
PCT/US2000/033060 WO2001041750A2 (en) 1999-12-10 2000-12-07 Combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino(2,3)-e indol-8-one and neuroleptics

Publications (2)

Publication Number Publication Date
EA200200656A1 true EA200200656A1 (en) 2002-12-26
EA005002B1 EA005002B1 (en) 2004-10-28

Family

ID=23821437

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200656A EA005002B1 (en) 1999-12-10 2000-12-07 NOVEL THERAPEUTIC COMBINATIONS OF (S)-2(BENZYLAMINO-METHYL)-2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO(2,3-e)-INDOL-8-ONE AND NEUROLEPTICS FOR TREATING OR PREVENTION OF PSYCHOTIC DISORDERS

Country Status (20)

Country Link
EP (1) EP1235570A2 (en)
JP (1) JP5557409B2 (en)
KR (1) KR100772854B1 (en)
CN (1) CN1230164C (en)
AR (1) AR026756A1 (en)
AU (1) AU784211B2 (en)
BR (1) BR0016168A (en)
CA (1) CA2396351C (en)
CZ (1) CZ20021880A3 (en)
EA (1) EA005002B1 (en)
HK (1) HK1045942A1 (en)
HU (1) HUP0203309A3 (en)
IL (2) IL149669A0 (en)
MX (1) MXPA02005649A (en)
NO (1) NO20022739L (en)
NZ (1) NZ519381A (en)
PL (1) PL355292A1 (en)
TW (1) TWI222864B (en)
WO (1) WO2001041750A2 (en)
ZA (1) ZA200205484B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06004752A (en) 2003-10-29 2006-07-05 Wyeth Corp Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof.
JP2008530229A (en) 2005-02-17 2008-08-07 ワイス Cycloalkyl fused indole, benzothiophene, benzofuran and indene derivatives
DK2254598T3 (en) * 2008-02-13 2013-07-29 Targacept Inc COMBINATION OF ALFA 7-NICOTINAGONISTS AND ANTI-CYCOTICS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2987484B2 (en) * 1995-03-16 1999-12-06 大塚製薬 株式会社 Method for producing carbostyril derivative
US5756532A (en) * 1995-11-06 1998-05-26 American Home Products Corporation Aminomethyl-2 3 8 9-tetrahydro-7H-1 4-dioxino 2 3-E!-indol-8-ones and derivatives
GB9627005D0 (en) * 1996-12-27 1997-02-12 Knoll Ag Therapeutic agents

Also Published As

Publication number Publication date
AU1949001A (en) 2001-06-18
CN1409633A (en) 2003-04-09
ZA200205484B (en) 2003-12-31
IL149669A (en) 2006-06-11
HUP0203309A3 (en) 2004-12-28
MXPA02005649A (en) 2004-09-10
WO2001041750A3 (en) 2002-02-14
JP2003516350A (en) 2003-05-13
AU784211B2 (en) 2006-02-23
CA2396351C (en) 2009-11-10
JP5557409B2 (en) 2014-07-23
KR100772854B1 (en) 2007-11-02
PL355292A1 (en) 2004-04-05
CZ20021880A3 (en) 2002-08-14
EA005002B1 (en) 2004-10-28
HK1045942A1 (en) 2002-12-20
EP1235570A2 (en) 2002-09-04
TWI222864B (en) 2004-11-01
CA2396351A1 (en) 2001-06-14
WO2001041750A2 (en) 2001-06-14
NZ519381A (en) 2004-04-30
NO20022739D0 (en) 2002-06-07
CN1230164C (en) 2005-12-07
BR0016168A (en) 2002-08-20
AR026756A1 (en) 2003-02-26
KR20030016207A (en) 2003-02-26
NO20022739L (en) 2002-06-07
HUP0203309A2 (en) 2003-01-28
IL149669A0 (en) 2002-11-10

Similar Documents

Publication Publication Date Title
ATE399553T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DEXTROMETHORPHAN AND QUINIDENE FOR THE TREATMENT OF NEUROLOGICAL DISEASES
FI963294A (en) Naphthylamides as central nervous system agents
DE69427704D1 (en) NEW (R) -5-CARBAMOYL-8-FLUOR-3-N, N-DISUBSTITUTED-AMINO-3,4-DIHYDRO-2H-1-BENZOPYRANE
BR0309875A (en) methods and compositions for treating peripheral nervous system disorders and novel compounds useful therefor
DE69736441D1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISEASES
ATE142877T1 (en) MELATONINE DERIVATIVES FOR THE TREATMENT OF SLEEP DISORDERS AND FOR PRE-ANESTHESIA
FI972308A (en) 2-Substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions containing them and methods for their use
SE9802208D0 (en) Novel compounds
YU13301A (en) Muscarinic agonists and antagonists
EA200000242A1 (en) FANHINONA APPLICATION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
DE69939075D1 (en) Pharmaceutical composition for the prevention and treatment of diseases associated with cell diseases of the fundus
DE69713571D1 (en) USE OF (+) - ALPHA- (2,3-DIMETHOXYPHENYL) -1 (2- (4-FLUOROPHENYL) ETHYL-4-PIPERIDINE METHANOL FOR THE TREATMENT OF DEPRESSIONS AND BIPOLAR DISEASES
SE9802209D0 (en) Novel compounds
EA200200656A1 (en) NEW THERAPEUTIC COMBINATIONS (S) -2- (BENZYLAMINOMETYL) -2,3,8,9-TETRAHYDRO-7H-1,4-DIOXIN [2,3-th] INDOL-8-SHE AND NEUROLEPTIC FOR TREATMENT OR PREVENTION OF PSYCHOLOGICAL
DE60221104D1 (en) SUBSTITUTED DIARYL HARVES AS STIMULATORS OF FAS-MEDIATED APOPTOSIS
TR199901385T2 (en) Piperidin t�revleri.
MX9704035A (en) Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof.
ATE271867T1 (en) TREATMENT OF URINARY INCONTINENCE AND COMPOSITION THEREOF
MX9704036A (en) 2-(2,3,5,6-tetrafluoro-4-pyridyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof.
NO20010984D0 (en) Use of R (+) - <alpha> - (2,3-dimethoxyphenyl) -1- [2- (4-fluorophenyl) ethyl] -4-piperidinemethanol for the treatment of sleep disorders
SE9803276D0 (en) Use of certain drugs for treating nerve root injury

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU